"
Team:Westminster/Project
From 2012.igem.org
(Difference between revisions)
| (6 intermediate revisions not shown) | |||
| Line 110: | Line 110: | ||
padding: 15px 20px; | padding: 15px 20px; | ||
border-radius: 10px; | border-radius: 10px; | ||
| + | } | ||
| + | div.three-columns { | ||
| + | padding-left: 20px; | ||
| + | overflow: auto; | ||
} | } | ||
div.column, img.column { | div.column, img.column { | ||
float: left; | float: left; | ||
width: 235px; | width: 235px; | ||
| - | + | margin: 10px 0px 50px 20px; | |
| - | margin: 10px 20px | + | |
border-radius: 10px; | border-radius: 10px; | ||
} | } | ||
| Line 149: | Line 152: | ||
<ul id="navigation-list"> | <ul id="navigation-list"> | ||
<li><a href="https://2012.igem.org/Team:Westminster" class="navlink">Home</a></li> | <li><a href="https://2012.igem.org/Team:Westminster" class="navlink">Home</a></li> | ||
| - | <li><a href="https://2012.igem.org/Team:Westminster/Team" class="navlink | + | <li><a href="https://2012.igem.org/Team:Westminster/Team" class="navlink">Team</a></li> |
<li><a href="https://igem.org/Team.cgi?year=2012&team_name=Westminster"class="navlink">Team Profile</a></li> | <li><a href="https://igem.org/Team.cgi?year=2012&team_name=Westminster"class="navlink">Team Profile</a></li> | ||
<li class="submenu-holder"> | <li class="submenu-holder"> | ||
| - | <a href="https://2012.igem.org/Team:Westminster/Project"class="navlink">Project</a> | + | <a href="https://2012.igem.org/Team:Westminster/Project/Overview"class="navlink active">Project</a> |
<ul class="submenu"> | <ul class="submenu"> | ||
| - | <li class="submenu-button"><a href="https://2012.igem.org/Team:Westminster/Overview"class="navlink">Overview</a></li> | + | <li class="submenu-button"><a href="https://2012.igem.org/Team:Westminster/Overview"class="navlink active">Overview</a></li> |
<li class="submenu-button"><a href="https://2012.igem.org/Team:Westminster/Problem"class="navlink">The Problem</a></li> | <li class="submenu-button"><a href="https://2012.igem.org/Team:Westminster/Problem"class="navlink">The Problem</a></li> | ||
<li class="submenu-button"><a href="https://2012.igem.org/Team:Westminster/Experiments"class="navlink">Experiments</a></li> | <li class="submenu-button"><a href="https://2012.igem.org/Team:Westminster/Experiments"class="navlink">Experiments</a></li> | ||
| Line 179: | Line 182: | ||
<div id="home-main-text"> | <div id="home-main-text"> | ||
<h2>Lorem Ipsum</h2> | <h2>Lorem Ipsum</h2> | ||
| - | <div | + | <div class="three-columns"> |
| - | <img class="column" src="https://static.igem.org/mediawiki/2012/4/4d/Westminster_team.png" width=" | + | <img class="column" src="https://static.igem.org/mediawiki/2012/4/4d/Westminster_team.png" width="255" height="220" /> |
| - | <img class="column" src="https://static.igem.org/mediawiki/2012/4/4d/Westminster_team.png" width=" | + | <img class="column" src="https://static.igem.org/mediawiki/2012/4/4d/Westminster_team.png" width="255" height="220" /> |
| - | <img class="column" src="https://static.igem.org/mediawiki/2012/4/4d/Westminster_team.png" width=" | + | <img class="column" src="https://static.igem.org/mediawiki/2012/4/4d/Westminster_team.png" width="255" height="220" /> |
</div><!-- #three-columns --> | </div><!-- #three-columns --> | ||
<h2>Lorem Ipsum</h2> | <h2>Lorem Ipsum</h2> | ||
Latest revision as of 19:53, 25 September 2012
Lorem Ipsum
Lorem Ipsum
Cancer recurrence is one of the fears that almost every patient undergoing chemotherapy develops. Recent findings suggest that only a small fraction of the tumor cells, called Cancer Stem Cells (CSC) are able to drive the growth of the tumor. CSC also show an increased drug resistance, and could remain unaffected after chemotherapy, eventually resulting in the formation of a new tumor.
Lorem Ipsum
Cancer recurrence is one of the fears that almost every patient undergoing chemotherapy develops. Recent findings suggest that only a small fraction of the tumor cells, called Cancer Stem Cells (CSC) are able to drive the growth of the tumor. CSC also show an increased drug resistance, and could remain unaffected after chemotherapy, eventually resulting in the formation of a new tumor.
